Filter
795
Filtered Results: 795
Text search:
Multi-drugresistant
Tuberculosis/MDR-TB
Featured
Recommendations
96
New Publications
241
Language
Document type
No document type
610
Studies & Reports
66
Guidelines
64
Manuals
21
Strategic & Response Plan
13
Training Material
9
Fact sheets
7
Situation Updates
5
Countries / Regions
Western and Central Europe
50
Eastern Europe
37
India
33
South Africa
29
Kenya
27
Malawi
16
Tanzania
16
Nepal
15
Myanmar / Burma
15
Zambia
14
Namibia
13
Ukraine
12
Bangladesh
12
Ethiopia
12
Rwanda
10
Cambodia
10
Asia
10
Liberia
10
Global
9
Nigeria
8
Uganda
8
Lesotho
7
Ghana
7
Latin America and the Carribbean
7
South–East Asia Region
7
Russia
7
Botswana
7
Sierra Leone
5
Mozambique
5
Indonesia
5
Colombia
4
Peru
4
Philippines
4
Germany
4
Tajikistan
3
Senegal
3
Zimbabwe
3
Pakistan
3
El Salvador
2
Benin
2
Cameroon
2
Guinea
2
Armenia
2
Africa
2
Congo, Democratic Republic of
2
Western Pacific Region
2
Argentina
2
Vietnam
2
Eswatini/ Swaziland
2
Switzerland
1
Timor Leste/ East Timor
1
Gambia
1
Albania
1
Estonia
1
Burkina Faso
1
Afghanistan
1
Jordan
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Paraguay
1
Turkmenistan
1
Maldives
1
East and Southern Africa
1
Papua New Guinea
1
Moldova
1
Sri Lanka
1
Romania
1
Georgia
1
Central African Republic
1
Bhutan
1
South Sudan
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
155
TB
69
Studies & Reports
58
Policies
52
Guidelines
26
Capacity Building
17
Pediatrics
13
Drugs & Medical Equipment
13
Statistics
11
Disease Prevention & Control
11
Community Health
10
Paediatrics
8
Women & Child Health
6
Bacteriology
5
Countries
5
Demograhic Health Surveys DHS
5
Infection Control & Prevention (IPC)
4
Public Health
3
Public Health
3
HIV & STI
3
Global Health
3
Communicable Diseases
2
Clinical Training
2
COVID-19
2
Community Health
2
Training Manuals
2
Humanitarian Crisis
2
General Guidelines
2
Health Systems
2
Primary Health Care
2
Pharmacy & Technology
1
Child Health
1
Buruli Ulcer
1
Diabetes
1
x MEDBOX Issue Brief & Annual Reports x
1
Monitoring & Evaluation
1
Palliative Care
1
Maternal & Child Health
1
Sex. & Repr. Rights
1
Clinical Guidelines
1
Palliative Care
1
Communicable Diseases
1
Gynaecology & Obstetrics
1
Nutrition
1
Maternal Health
1
Non-communicable Diseases
1
Reproductive Health
1
Food Security & Nutrition
1
Toolboxes
Drug resistant TB
55
Prevention & Control
36
Detection & Diagnosis
33
Adults
30
TB & Prisoners
30
Children
22
Eastern Europe & Central Asia
21
TB & Other Vulnerable Populations
19
Advocacy & Communication
18
Training
17
Disease Prevention & Control
16
Reports & Studies
16
Reports
15
Country specific
14
Research & Access
14
SEAR (South-east Asia Region)
14
Eastern Europe and central Asia
14
Policies & Strategies
13
Childhood TB
13
TB/HIV Coinfection
11
Kenya
10
TB
9
Ukraine
8
International
8
South Africa
7
Rwanda
7
Drug resistance
7
General
7
HIV &TB
7
Policies and guidelines
7
Children & Adolescents
6
Country Specific
6
General
6
TB/HIV Global
6
Tuberculosis
6
Western & Central Europe
6
South-east Asia Region
6
Epidemiology
6
TB & Drug Abuse
5
Vaccines & Immunization
5
Namibia
5
Laboratory
5
IEC Materials
5
Ethiopia
5
Ghana
5
Malawi
5
Assessment
5
HIV and coinfection
5
AmR (Region of Americas)
5
Moldova
4
Clinical Aspects
4
WPRO (Western Pacific Region)
4
National Policies
4
Studies
4
TB/HIV
4
Colombia
4
Essential Medicines & Devices Lists
4
Romania
4
Germany
4
Uganda
4
Clinical Guidelines
4
Kazakhstan
4
Biosafety
3
IPC
3
Azerbaijan
3
Clinical Aspects, Treatment & Prevention
3
Europe
3
TB
3
Mozambique
3
Georgia
3
Workplace
3
Sustainable Development Goals
3
Estonia
3
Peru
3
Essential Medicines
3
Rational use of Medicine
3
Health Financing Toolbox
3
Co-Morbidities (except TB)
3
AR (African Region)
3
Nutrition
3
Nigeria
3
Tajikistan
3
Lobby and Advocacy
3
HIV in Key Populations
3
Behaviour Change/Life Skill Education
2
General Reports
2
Surveillance
2
Eastern Mediterranean Region
2
Eastern Europe
2
People who injecting Drugs
2
Prophylaxis
2
SOPs
2
Country Guidelines
2
Russia
2
Climate & Health
2
Essential List
2
Country specific documents
2
Latin America
2
TB/COVID-19
2
Community Health Workers CHW
2
Argentina
2
General Guidelines for Rational Use
2
Guidelines & Manuals
2
Armenia
2
Botswana
2
Community Worker
2
Prophylactic Treatment
2
Stewardship
2
Latin America & the Carribean
2
HIV / AIDS
2
Community-based Mental Health Care
2
Antiretroviral Treatment ART
2
Infection Control
2
Global Health Financing
2
Prisoners
2
Volunteers
2
Agriculture & Veterinary
1
Ebola Prevention & Control
1
Surveillance
1
Policies & Strategies
1
Treatment & Prevention
1
Clinical Guidelines
1
Pediatrics
1
Zambia
1
Introduction to Global Health
1
WASH
1
Assessment & Response
1
Children
1
Policies
1
Public Health
1
Treatment Guidelines HIV
1
Social Worker
1
Public Health
1
Sexually Transmitted Infections
1
Communication & Training
1
El Niño
1
Others
1
Tools for Rational use
1
Hepatitis
1
Global
1
IEC Materials
1
Latin America
1
Vaccination
1
Adherence
1
African Region
1
Discrimination & Stigma
1
Advocacy
1
Laboratory
1
Clinical aspects
1
Belarus
1
Medical professionals
1
Key Resources
1
Communication & Training
1
Research & Development
1
Health Personnel
1
General
1
Infection Prevention & Hygiene
1
Clinical Guidelines
1
Global Impact: Socio-economic, health services, TB & HIV
1
Hygiene
1
Latin America
1
Overview
1
El Salvador
1
Urban health
1
Prices and Patents
1
Model Formulary
1
Pharmacy Practice
1
Situation Reports & Updates
1
Health Care Systems
1
Health Impact & Climate Change
1
Health Care In Conflict Settings
1
Health Worker
1
General Information
1
General Information & Methodology
1
Clinical Aspects & Diagnosis
1
Air Pollution
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Asia and Pacific
1
Liberia
1
General Aspects
1
Regional Reports & Guidelines, others
1
Human Rights & the Right to Health
1
Education of students & professionals
1
Lesotho
1
General Public
1
Others
1
Overview & Statistics
1
MHPSS Guidelines
1
Global Health Action
1
AMR
1
Urban Health
1
Global Burden of Disease
1
Interim policy guidance
This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis (TB) using molecular typing data reported by European Union (EU)/European Economic Area (EEA) Member States for 2015 and the preceding years.
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD...
The term "Programmatic Management of Drug Resistant TB" (PMD...
For full course visit: https://drtbnetwork.org/training-course-MDR-TB
This course has been designed to take three days. It is composed of lectures, in-class readings, exercises, case discussions, and quizzes, which together are intended to provide a diverse and compelling learning experience for pa...
This guide provides practical, step-by-step guidance on how to organize, implement, and monitor community-based care for DR TB. It is equally useful for program planning or supervision. The target audience for this guide is TB Program Managers, governments, policy makers, nongovernmental organizatio...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
INT J TUBERC LUNG DIS 22(2):197–205 http://dx.doi.org/10.5588/ijtld.17.0245
A large meta-analysis of observational studies that provided the basis for the recent makeover of global recommendations for multidrug-resistant tuberculosis (MDR-TB) treatment shows that newer and repurposed drugs produced better outcomes and fewer deaths than older treatments.
The meta-analysis...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in district hospitals and some accredited health centres) wil...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...
Tuberculosis (TB) is an infectious disease that usually affects the lungs, though it can affect any organ in the body. It can develop when bacteria spread through droplets in the air. TB can be fatal, but in many cases, TB is preventable and treatable. This report examines the human rights impact of...
Rev Panam Salud Publica. 2021;45:e74.
Some characteristics of patients and healthcare providers influence treatment success in MDR-TB cases. Physicians’ and nurses’ knowledge about MDR-TB must be improved, and follow-up of MDR-TB patients who are living with HIV and of those affiliated with the...
